img

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

There are commercial vaccines available containing either a live modified PRRS virus or a dead PRRS virus, both of which are used to increase the immunity to these strains of the infection. These vaccines are licensed in both breeding or growing pigs.
Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market is projected to reach US$ 696.7 million in 2029, increasing from US$ 363 million in 2022, with the CAGR of 10.2% during the period of 2024 to 2029. Demand from Government Tender and Market Sales are the major drivers for the industry.
Porcine vaccines play a crucial role in preventing and controlling various viral, bacterial, and parasitic diseases in pigs. The market is driven by factors such as the growth of the swine industry, rising awareness about the benefits of vaccination, and the implementation of stringent animal health regulations. Additionally, advancements in vaccine technology, such as the development of more efficacious and safer vaccines, are fueling market growth. However, challenges such as high costs associated with vaccine development and production, and the presence of counterfeit vaccines in some regions, may hamper market growth. With the continuous focus on disease prevention and the need to ensure a healthy pig population, the porcine vaccines market is expected to witness sustained growth in the coming years.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


CAHIC
Boehringer Ingelheim
MSD Animal Health
Sino Pharm
Ceva
ChengDu Tecbond
Ringpu Biology
Qilu Animal
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tecon
Zoetis
WINSUN
PULILE
Segment by Type
Live Vaccines
Killed Vaccines

Segment by Application


Government Tender
Market Sales

Segment by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines introduction, etc. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Overview
1.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Overview
1.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Killed Vaccines
1.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Type
1.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Type (2018-2029)
1.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Type (2018-2024)
2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competition by Company
2.1 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (2018-2024)
2.2 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue (2018-2024)
2.3 Global Top Players by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Competitive Situation and Trends
2.5.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market
2.8 Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Status and Outlook by Region
3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Region
3.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Region
3.3.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2024-2029)
3.3.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2024-2029)
3.3.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Application
4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Segment by Application
4.1.1 Government Tender
4.1.2 Market Sales
4.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size by Application
4.2.1 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Overview by Application (2018-2029)
4.2.2 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Breakdown by Application (2018-2024)
5 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
5.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
5.1.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2024)
5.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
5.2.1 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
5.2.2 North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
6 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
6.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
6.1.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
6.2.1 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
6.2.2 Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
7 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Region
7.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Region (2024-2029)
8 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
8.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
8.1.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
8.2.1 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
8.2.2 Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
9 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines by Country
9.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 CAHIC
10.1.1 CAHIC Company Information
10.1.2 CAHIC Introduction and Business Overview
10.1.3 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.1.5 CAHIC Recent Development
10.2 Boehringer Ingelheim
10.2.1 Boehringer Ingelheim Company Information
10.2.2 Boehringer Ingelheim Introduction and Business Overview
10.2.3 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.2.5 Boehringer Ingelheim Recent Development
10.3 MSD Animal Health
10.3.1 MSD Animal Health Company Information
10.3.2 MSD Animal Health Introduction and Business Overview
10.3.3 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.3.5 MSD Animal Health Recent Development
10.4 Sino Pharm
10.4.1 Sino Pharm Company Information
10.4.2 Sino Pharm Introduction and Business Overview
10.4.3 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.4.5 Sino Pharm Recent Development
10.5 Ceva
10.5.1 Ceva Company Information
10.5.2 Ceva Introduction and Business Overview
10.5.3 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.5.5 Ceva Recent Development
10.6 ChengDu Tecbond
10.6.1 ChengDu Tecbond Company Information
10.6.2 ChengDu Tecbond Introduction and Business Overview
10.6.3 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.6.5 ChengDu Tecbond Recent Development
10.7 Ringpu Biology
10.7.1 Ringpu Biology Company Information
10.7.2 Ringpu Biology Introduction and Business Overview
10.7.3 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.7.5 Ringpu Biology Recent Development
10.8 Qilu Animal
10.8.1 Qilu Animal Company Information
10.8.2 Qilu Animal Introduction and Business Overview
10.8.3 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.8.5 Qilu Animal Recent Development
10.9 DHN
10.9.1 DHN Company Information
10.9.2 DHN Introduction and Business Overview
10.9.3 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.9.5 DHN Recent Development
10.10 CAVAC
10.10.1 CAVAC Company Information
10.10.2 CAVAC Introduction and Business Overview
10.10.3 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.10.5 CAVAC Recent Development
10.11 Komipharm
10.11.1 Komipharm Company Information
10.11.2 Komipharm Introduction and Business Overview
10.11.3 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.11.5 Komipharm Recent Development
10.12 Agrovet
10.12.1 Agrovet Company Information
10.12.2 Agrovet Introduction and Business Overview
10.12.3 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.12.5 Agrovet Recent Development
10.13 Bioveta
10.13.1 Bioveta Company Information
10.13.2 Bioveta Introduction and Business Overview
10.13.3 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.13.5 Bioveta Recent Development
10.14 Jinyu Bio-Technology
10.14.1 Jinyu Bio-Technology Company Information
10.14.2 Jinyu Bio-Technology Introduction and Business Overview
10.14.3 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.14.5 Jinyu Bio-Technology Recent Development
10.15 Phibro Animal Health
10.15.1 Phibro Animal Health Company Information
10.15.2 Phibro Animal Health Introduction and Business Overview
10.15.3 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.15.5 Phibro Animal Health Recent Development
10.16 Tecon
10.16.1 Tecon Company Information
10.16.2 Tecon Introduction and Business Overview
10.16.3 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.16.5 Tecon Recent Development
10.17 Zoetis
10.17.1 Zoetis Company Information
10.17.2 Zoetis Introduction and Business Overview
10.17.3 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.17.5 Zoetis Recent Development
10.18 WINSUN
10.18.1 WINSUN Company Information
10.18.2 WINSUN Introduction and Business Overview
10.18.3 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.18.5 WINSUN Recent Development
10.19 PULILE
10.19.1 PULILE Company Information
10.19.2 PULILE Introduction and Business Overview
10.19.3 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Products Offered
10.19.5 PULILE Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain Analysis
11.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Dynamics
11.4.1 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industry Trends
11.4.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
11.4.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
11.4.4 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors
12.3 Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Killed Vaccines
Table 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 5. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2018-2024) & (USD/K Unit)
Table 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (M Units)
Table 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type (2024-2029)
Table 13. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Type (2024-2029) & (USD/K Unit)
Table 14. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (M Units)
Table 15. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Type (2018-2024)
Table 17. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Type (2018-2024)
Table 19. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Type (2018-2024)
Table 21. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units) by Type (2018-2024)
Table 23. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Company (2018-2024) & (M Units)
Table 25. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Share by Company (2018-2024)
Table 26. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Company (2018-2024) & (USD/K Unit)
Table 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market
Table 33. Key Manufacturers Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (M Units)
Table 37. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 41. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (M Units)
Table 42. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Region (2024-2029)
Table 45. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (US$ Million), Price (USD/K Unit) and Gross Margin (2024-2029)
Table 46. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (M Units)
Table 48. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2018-2024) & (USD/K Unit)
Table 52. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (M Units)
Table 53. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application (2024-2029)
Table 56. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Price by Application (2024-2029) & (USD/K Unit)
Table 57. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) (M Units)
Table 58. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) (M Units)
Table 60. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) (M Units)
Table 62. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) (M Units)
Table 64. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) (M Units)
Table 66. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 68. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 72. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 76. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 80. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (M Units)
Table 84. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (M Units)
Table 88. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 92. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 96. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (M Units)
Table 100. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (M Units)
Table 104. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Country (2024-2029)
Table 107. CAHIC Company Information
Table 108. CAHIC Introduction and Business Overview
Table 109. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 110. CAHIC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 111. CAHIC Recent Development
Table 112. Boehringer Ingelheim Company Information
Table 113. Boehringer Ingelheim Introduction and Business Overview
Table 114. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 115. Boehringer Ingelheim Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 116. Boehringer Ingelheim Recent Development
Table 117. MSD Animal Health Company Information
Table 118. MSD Animal Health Introduction and Business Overview
Table 119. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 120. MSD Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 121. MSD Animal Health Recent Development
Table 122. Sino Pharm Company Information
Table 123. Sino Pharm Introduction and Business Overview
Table 124. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 125. Sino Pharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 126. Sino Pharm Recent Development
Table 127. Ceva Company Information
Table 128. Ceva Introduction and Business Overview
Table 129. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 130. Ceva Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 131. Ceva Recent Development
Table 132. ChengDu Tecbond Company Information
Table 133. ChengDu Tecbond Introduction and Business Overview
Table 134. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 135. ChengDu Tecbond Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 136. ChengDu Tecbond Recent Development
Table 137. Ringpu Biology Company Information
Table 138. Ringpu Biology Introduction and Business Overview
Table 139. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 140. Ringpu Biology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 141. Ringpu Biology Recent Development
Table 142. Qilu Animal Company Information
Table 143. Qilu Animal Introduction and Business Overview
Table 144. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 145. Qilu Animal Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 146. Qilu Animal Recent Development
Table 147. DHN Company Information
Table 148. DHN Introduction and Business Overview
Table 149. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 150. DHN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 151. DHN Recent Development
Table 152. CAVAC Company Information
Table 153. CAVAC Introduction and Business Overview
Table 154. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 155. CAVAC Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 156. CAVAC Recent Development
Table 157. Komipharm Company Information
Table 158. Komipharm Introduction and Business Overview
Table 159. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 160. Komipharm Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 161. Komipharm Recent Development
Table 162. Agrovet Company Information
Table 163. Agrovet Introduction and Business Overview
Table 164. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 165. Agrovet Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 166. Agrovet Recent Development
Table 167. Bioveta Company Information
Table 168. Bioveta Introduction and Business Overview
Table 169. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 170. Bioveta Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 171. Bioveta Recent Development
Table 172. Jinyu Bio-Technology Company Information
Table 173. Jinyu Bio-Technology Introduction and Business Overview
Table 174. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 175. Jinyu Bio-Technology Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 176. Jinyu Bio-Technology Recent Development
Table 177. Phibro Animal Health Company Information
Table 178. Phibro Animal Health Introduction and Business Overview
Table 179. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 180. Phibro Animal Health Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 181. Phibro Animal Health Recent Development
Table 182. Tecon Company Information
Table 183. Tecon Introduction and Business Overview
Table 184. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 185. Tecon Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 186. Tecon Recent Development
Table 187. Zoetis Company Information
Table 188. Zoetis Introduction and Business Overview
Table 189. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 190. Zoetis Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 191. Zoetis Recent Development
Table 192. WINSUN Company Information
Table 193. WINSUN Introduction and Business Overview
Table 194. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 195. WINSUN Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 196. WINSUN Recent Development
Table 197. PULILE Company Information
Table 198. PULILE Introduction and Business Overview
Table 199. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales (M Units), Revenue (Million USD), Price (USD/K Unit) and Gross Margin (2018-2024)
Table 200. PULILE Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product
Table 201. PULILE Recent Development
Table 202. Key Raw Materials Lists
Table 203. Raw Materials Key Suppliers Lists
Table 204. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Trends
Table 205. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Drivers
Table 206. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Challenges
Table 207. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Restraints
Table 208. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Distributors List
Table 209. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Downstream Customers
Table 210. Research Programs/Design for This Report
Table 211. Key Data Information from Secondary Sources
Table 212. Key Data Information from Primary Sources
List of Figures
Figure 1. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Product Picture
Figure 2. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Status and Outlook (2018-2029) & (M Units)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 7. Product Picture of Killed Vaccines
Figure 8. Global Killed Vaccines Sales YoY Growth (2018-2029) & (M Units)
Figure 9. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Type in 2022 & 2029
Figure 11. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Revenue in 2022
Figure 23. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Government Tender
Figure 25. Global Government Tender Sales YoY Growth (2018-2029) & (M Units)
Figure 26. Product Picture of Market Sales
Figure 27. Global Market Sales Sales YoY Growth (2018-2029) & (M Units)
Figure 28. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales by Application (2018-2029) & (US$ Million)
Figure 29. Global Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share by Application in 2022 & 2029
Figure 30. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Manufacturing Cost Structure
Figure 41. Porcine Reproductive Respiratory Syndrome (PRRS) Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries